The American College of Chest Physicians Evidence-Based Educational Guidelines for Continuing Medical Education Interventions Estimating Effect Size

To the Editor:
We appreciate the commentary of Norman 1 regarding the methodology of our evidence-based review of the effectiveness of continuing medical education (CME), and agree with him that reporting effect size can be extremely useful in reporting results. 2 Synthesizing the results of educational interventions represents one of the methodological challenges to performing systematic reviews in health care. 3 The studies in our review differed in many important ways (used nonstandardized definitions of CME and targeted multiple types of objectives across vastly different audiences and content areas), and often were flawed in the metrics they used and in how those metrics were reported. 4 These limitations in the primary literature led to a qualitative synthesis of the evidence, as an aggregate estimate of effect size could have implied greater confidence in the results than would have been appropriate.
In conclusion, we strongly lend our voice to the importance of estimating effect size in systematic reviews of educational interventions and recommend that original studies of CME give more attention to using valid measures of effectiveness that would allow such estimates. 
Diagnosing Obstructive Sleep Apnea in the Setting of Comorbid Pulmonary Disease
To the Editor:
In a recent "Postgraduate Education Corner" report in CHEST (December 2008), Benson and Schwarz 1 reported on a young woman with recurrent hemoptysis resulting from pauciimmune pulmonary capillaritis exacerbated by negative-pressure pulmonary hemorrhage secondary to presumed coexisting obstructive sleep apnea (OSA). The authors described a detailed evaluation regarding the patient's pulmonary capillaritis that serves as a worthy example for pulmonologists in training.
In contrast, the approach taken regarding the patient's tentative diagnosis of OSA was markedly flawed, and it is concerning that this could misinform trainees regarding the appropriate evaluation, diagnosis, and treatment of OSA. Although the authors presumed a high probability of OSA based on the patient's physical examination, they did not report that they obtained a sleep history, which should be standard in the evaluation of OSA. The diagnostic test used in this patient, who had a waking oxygen saturation of 89% while breathing 8 L/min supplemental oxygen, was overnight oximetry. There is no description provided of the oximetry results. This may be because there has been no validation of this testing and no consensus on how to interpret overnight oximetry for the purpose of evaluating OSA in otherwise healthy individuals. 2 In patients such as the one whose case was described, the utility of oximetry is even more problematic, because the false-positive rate increases with underlying pulmonary disease and the false-negative rate increases with the administration of supplemental oxygen.
An evidence-based practice parameter guideline 3 issued by the American Academy of Sleep Medicine has strongly recommended against the use of even multichannel unattended monitoring for OSA diagnosis in patients with underlying pulmonary disease. Similarly, recent practice parameter guidelines 4 state that, as a standard of care, autotitrating positive airway pressure should not be used to determine continuous positive airway pressure (CPAP) levels in patients with underlying lung disease. In addition, in the case of the patient described by Benson and Schwarz, 1 the use of hydrocodone predisposed her to increased risk for central apneas, which would also be a contraindication for autotitration. While the treatment of acutely ill patients who are too sick to undergo formal polysomnography is challenging, and the risks of empiric CPAP use in the short term are relatively low, it is clear that once this patient's clinical status improved, an appropriate evaluation should have been performed to verify the diagnosis of OSA, given the burden imposed by lifetime CPAP therapy.
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